Tempo Scan Pacific Tbk PT
IDX:TSPC
Tempo Scan Pacific Tbk PT?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 910.5625
2 840
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Tempo Scan Pacific Tbk PT hold over its rivals?
What risks and challenges
does Tempo Scan Pacific Tbk PT face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Tempo Scan Pacific Tbk PT.
Provide an overview of the primary business activities
of Tempo Scan Pacific Tbk PT.
What unique competitive advantages
does Tempo Scan Pacific Tbk PT hold over its rivals?
What risks and challenges
does Tempo Scan Pacific Tbk PT face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Tempo Scan Pacific Tbk PT.
Provide P/S
for Tempo Scan Pacific Tbk PT.
Provide P/E
for Tempo Scan Pacific Tbk PT.
Provide P/OCF
for Tempo Scan Pacific Tbk PT.
Provide P/FCFE
for Tempo Scan Pacific Tbk PT.
Provide P/B
for Tempo Scan Pacific Tbk PT.
Provide EV/S
for Tempo Scan Pacific Tbk PT.
Provide EV/GP
for Tempo Scan Pacific Tbk PT.
Provide EV/EBITDA
for Tempo Scan Pacific Tbk PT.
Provide EV/EBIT
for Tempo Scan Pacific Tbk PT.
Provide EV/OCF
for Tempo Scan Pacific Tbk PT.
Provide EV/FCFF
for Tempo Scan Pacific Tbk PT.
Provide EV/IC
for Tempo Scan Pacific Tbk PT.
Show me price targets
for Tempo Scan Pacific Tbk PT made by professional analysts.
What are the Revenue projections
for Tempo Scan Pacific Tbk PT?
How accurate were the past Revenue estimates
for Tempo Scan Pacific Tbk PT?
What are the Net Income projections
for Tempo Scan Pacific Tbk PT?
How accurate were the past Net Income estimates
for Tempo Scan Pacific Tbk PT?
What are the EPS projections
for Tempo Scan Pacific Tbk PT?
How accurate were the past EPS estimates
for Tempo Scan Pacific Tbk PT?
What are the EBIT projections
for Tempo Scan Pacific Tbk PT?
How accurate were the past EBIT estimates
for Tempo Scan Pacific Tbk PT?
Compare the revenue forecasts
for Tempo Scan Pacific Tbk PT with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Tempo Scan Pacific Tbk PT and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Tempo Scan Pacific Tbk PT against its competitors.
Analyze the profit margins
(gross, operating, and net) of Tempo Scan Pacific Tbk PT compared to its peers.
Compare the P/E ratios
of Tempo Scan Pacific Tbk PT against its peers.
Discuss the investment returns and shareholder value creation
comparing Tempo Scan Pacific Tbk PT with its peers.
Analyze the financial leverage
of Tempo Scan Pacific Tbk PT compared to its main competitors.
Show all profitability ratios
for Tempo Scan Pacific Tbk PT.
Provide ROE
for Tempo Scan Pacific Tbk PT.
Provide ROA
for Tempo Scan Pacific Tbk PT.
Provide ROIC
for Tempo Scan Pacific Tbk PT.
Provide ROCE
for Tempo Scan Pacific Tbk PT.
Provide Gross Margin
for Tempo Scan Pacific Tbk PT.
Provide Operating Margin
for Tempo Scan Pacific Tbk PT.
Provide Net Margin
for Tempo Scan Pacific Tbk PT.
Provide FCF Margin
for Tempo Scan Pacific Tbk PT.
Show all solvency ratios
for Tempo Scan Pacific Tbk PT.
Provide D/E Ratio
for Tempo Scan Pacific Tbk PT.
Provide D/A Ratio
for Tempo Scan Pacific Tbk PT.
Provide Interest Coverage Ratio
for Tempo Scan Pacific Tbk PT.
Provide Altman Z-Score Ratio
for Tempo Scan Pacific Tbk PT.
Provide Quick Ratio
for Tempo Scan Pacific Tbk PT.
Provide Current Ratio
for Tempo Scan Pacific Tbk PT.
Provide Cash Ratio
for Tempo Scan Pacific Tbk PT.
What is the historical Revenue growth
over the last 5 years for Tempo Scan Pacific Tbk PT?
What is the historical Net Income growth
over the last 5 years for Tempo Scan Pacific Tbk PT?
What is the current Free Cash Flow
of Tempo Scan Pacific Tbk PT?
Discuss the annual earnings per share (EPS)
trend over the past five years for Tempo Scan Pacific Tbk PT.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
ID |
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
10.3T IDR | 3.8 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
751.3B USD | 36.3 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
366.7B USD | 12.3 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK | 12.8 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
206.3B CHF | 9.4 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
186.5B CHF | 10.6 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
159.1B GBP | 130.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
199.5B USD | 8.5 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 261.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
137.9B USD | 7.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
ID |
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Average EV/EBITDA:
394.5
3.8
|
N/A | N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
36.3
|
30%
|
1.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
12.3
|
7%
|
1.8 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
12.8
|
13%
|
1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.4
|
5%
|
1.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
10.6
|
5%
|
2.1 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
130.6
|
10%
|
13.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
8.5
|
8%
|
1.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
261.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.5
|
2%
|
3.8 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.